fremanezumab-vfrm (Ajovy)
fremanezumab-vfrm is an FDA-licensed reference biologic from Teva Branded Pharmaceutical Products R&D, Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2018
Reference approved
Reference product
Ajovy fremanezumab-vfrm
Teva Branded Pharmaceutical Products R&D, Inc.
- Approved
- Sep 14, 2018
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for fremanezumab-vfrm, in chronological order.
Reference approval
Approval date of the reference fremanezumab-vfrm product.
7 yr 10 mo ago
Frequently asked questions
Are there biosimilars approved for fremanezumab-vfrm (Ajovy)?
No 351(k) biosimilars or interchangeable biosimilars referencing fremanezumab-vfrm are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.